1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Breast cancer

Imlunestrant for treating oestrogen receptor-positive HER2-negative advanced breast cancer after endocrine therapy [ID6373]

In development [GID-TA11439] Expected publication date: TBC

  • Project information
  • Project documents

NIHRIO BN: 33651-Imlunestrant-for-Breast-Cancer-V1.0-SEP2023-NON-CONF-.pdf (nihr.ac.uk)